Clinical Trial

Use of the PTEye Device to Reduce Inadvertent Parathyroidectomy During Thyroid Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 11, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Inadvertent Parathyroidectomy (IP) during thyroid surgery may lead to transient or permanent hypoparathyroidism and hypocalcemia, which represents significant morbidity. Patients that suffer from IP and its clinical consequences often require longer duration of hospitalization and additional inpatient treatment and prescription medications. ProMedica performs a large number of endocrine procedures, so the use of novel technology to aid in the intra operative identification of parathyroid glands may ultimately offer decreased morbidity to patients. The goal of this study is to find out if using the PTEye device (a device that uses infrared light to find the Parathyroid gland) lowers the amount of times a surgeon accidentally takes out the Parathyroid gland while trying to take out the Thyroid gland in surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-13.
Trial Details
NCT Number NCT06927245
Lead Sponsor ProMedica Health System
Conditions Thyroid Surgery, Inadvertent Parathyroidectomy, Enlarged Thyroid
Enrollment 25 participants
Start Date 2025-09-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-11